Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer

References

• Vogelstein B, Kinzler K W. The multistep nature of cancer. Trends Genet 1993; 9: 138–41
   PubMed Web of Science ®Google Scholar
• Vogt P K. Cancer genes. West J Med 1993; 158: 273–8
   PubMedGoogle Scholar
• Blackburn E H. Telomerases. Annu Rev Biochem 1992; 61: 113–29
   PubMed Web of Science ®Google Scholar
• Nugent C I, Lundblad V. The telomerase reverse transcriptase: components and regulation. Genes Dev 1998; 12: 1073–85
   PubMed Web of Science ®Google Scholar
• Shay J W, Wright W E. The reactivation of telomerase activity in cancer progression. Trends Genet 1996; 12: 129–31
   PubMed Web of Science ®Google Scholar
• Holt S E, Shay J E. Role of telomerase in cellular proliferation and cancer. J Cell Physiol 1999; 180: 10–18
   PubMed Web of Science ®Google Scholar
• Wright W E, Shay J W. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr Opin Genet Dev 2001; 11: 98–103
   PubMed Web of Science ®Google Scholar
• Kim N W, Piatyszek M A, Prowse K R, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–5
   PubMed Web of Science ®Google Scholar
• Shay J W, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787–91
   PubMed Web of Science ®Google Scholar
• Feng J, Funk W D, Wang S S, et al. The RNA component of human telomerase. Science 1995; 269: 1236–41
   PubMed Web of Science ®Google Scholar
• Meyerson M, Counter C M, Eatom E N, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997; 90: 785–95
   PubMed Web of Science ®Google Scholar
• Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinoma. Nat Genet 1998; 18: 65–68
   PubMed Web of Science ®Google Scholar
• Fang D C, Joanne Y, Luo Y, et al. Detection of telomerase activity in biopsy samples of colorectal cancer. J Gastroenterol Hepatol 1999; 14: 328–32
   PubMed Web of Science ®Google Scholar
• Yan P, Saraga E P, Bouzourene H, et al. Telomerase activation in colorectal cacinogenesis. J Pathol 1999; 189: 207–12
   PubMed Web of Science ®Google Scholar
• Niiyama H, Mizumoto K, Sato N, et al. Quantitative analysis of hTERT mRNA expression in colorectal cancer. Am J Gastroenterol 2001; 96: 1895–900
   PubMed Web of Science ®Google Scholar
• Shoji Y, Yoshinaga K, Inoue A, Iwasaki A, et al. Quantification of telomerase activity in sporadic colorectal carcinoma. Cancer 2000; 88: 1304–9
   PubMed Web of Science ®Google Scholar
• Kanamaru T, Tanaka K I, Kotani J, et al. Telomerase activity and hTERT in development and progression of adenoma to colorectal cancer. Int J Mol Med 2002; 10: 205–10
   PubMed Web of Science ®Google Scholar
• Ghori A, Usselmann B, Ferryman S, et al. Telomerase expression of malignant epithelial cells correlates with Dukes' stage in colorectal cancer. Colorectal Dis 2002; 4: 441–6
   PubMedGoogle Scholar
• Bustin S A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25: 169–93
   PubMed Web of Science ®Google Scholar
• De Kok J B, Ruers T J, van Muijen G N, et al. Real-Time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Clin Chem 2000; 46: 313–8
   PubMed Web of Science ®Google Scholar
• Cheng A J, Tang R P, Wang J Y, et al. Possible role of telomerase activation in the cancer predisposition of patients with hereditary nonpolyposis colorectal cancers. J Natl Cancer Inst 1998; 90: 316–21
   PubMedGoogle Scholar
• Kawanishi-Tabata R, Lopez F, Fratantonio S, et al. Telomerase activity in stage II colorectal carcinoma. Cancer 2002; 95: 1834–39
   PubMed Web of Science ®Google Scholar
• Myung S J, Yang S K, Chang H S, et al. Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients. J Gastroenterol 2005; 20: 1578–83
   Web of Science ®Google Scholar
• Tahara H, Yasui W, Tahara E, et al. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in colorectal tumor and non-tumor tissue sections. Oncogene 1999; 18: 1561–7
   PubMed Web of Science ®Google Scholar
• Gertler R, Rosenberg R, Stricker D, et al. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma. Cancer 2002; 95: 2103–11
   PubMed Web of Science ®Google Scholar
• Ulaner G A, Hu J F, Vu T H, et al. Regulation of telomerase by alternative splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary endometrium and myometrium. Int J Cancer 2000; 85: 330–5
   PubMed Web of Science ®Google Scholar
• Lledo S M, Garcia-Granero E, Dasi F, et al. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer. Colorectal Dis 2004; 6: 236–42
   PubMedGoogle Scholar
• Iacopetta B. Are there two sides to colorectal cancer?. Int J Cancer 2002; 101: 403–8
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Liefers G J, Los L C, et al. Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 2001; 195: 171–8
   PubMed Web of Science ®Google Scholar
• Birkenkamp-Demtroder K, Olesen S H, et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005; 54: 374–84
   PubMed Web of Science ®Google Scholar